Stockscreener 앱 받기
0.71
1.42%
-0.0102
시간 외 거래:
.71
전일 마감가:
$0.7202
열려 있는:
$0.7083
하루 거래량:
102.71K
Relative Volume:
0.74
시가총액:
$4.55M
수익:
$1.10M
순이익/손실:
$-11.23M
주가수익비율:
-0.3506
EPS:
-2.025
순현금흐름:
$-6.61M
1주 성능:
-10.69%
1개월 성능:
+26.56%
6개월 성능:
-1.80%
1년 성능:
-22.32%
1일 변동 폭
$0.6501
$0.7325
1주일 범위
$0.6501
$0.839
52주 변동 폭
$0.48
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
명칭
Matinas Biopharma Holdings Inc
전화
908-443-1860
주소
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.71 | 4.82M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 재개 | Piper Sandler | Overweight |
| 2020-01-27 | 개시 | Piper Sandler | Overweight |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2020-01-09 | 개시 | Aegis Capital | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Matinas Biopharma Holdings Inc 주식(MTNB)의 최신 뉴스
MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Highlights Cost DisciplineEarnings Manipulation Risk - newsline.com
MTNB Q4 2024 Earnings: EPS Beats Estimates as Biotech Continues Clinical DevelopmentEarnings Analysis - newsline.com
MTNB Q4 2024 Earnings: EPS Surprise Beat Amidst Pre-Revenue ChallengesMid-Term Outlook - newsline.com
Matinas Biopharma (MTNB) Slips to $0.79 as Stock Tests Key Support LevelExtension Target - newsline.com
MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Boosts Investor SentimentEarnings Call Q&A - newsline.com
MSN Money - MSN
MTNB Stock Price, Quote & Chart | MATINAS BIOPHARMA HOLDINGS I (NYSEARCA:MTNB) - ChartMill
Matinas Biopharma (MTNB) Holds Near Support Amid Cautious Market SentimentAndrews Pitchfork - newsline.com
MTNB Q4 2024 Earnings: Narrowing Losses Surprise as Biotech Advances Pipeline Without RevenueEarnings Per Share - The Legal Advocate
MTNB Q4 2024 Earnings: Narrowed Loss Beats Estimates as Matinas Advances PipelineProfit Recovery Report - newsline.com
MTNB Q4 2024 Earnings: Matinas Biopharma Reports Narrower-Than-Expected LossAnalyst Consensus Shift - Newser
MTNB Technical Analysis | Trend, Signals & Chart Patterns | MATINAS BIOPHARMA HOLDINGS I (NYSEARCA:MTNB) - ChartMill
Matinas Biopharma Holdings, Inc. Common Stock (NY: MTNB - The Chronicle-Journal
TradingKey - TradingKey
What Matinas (MTNB) is building for next year | Q4 2024: Earnings Beat EstimatesProfessional Trade Ideas - Newser
Matinas BioPharma (NYSE: MTNB) warns on going concern amid low cash and NYSE notice - Stock Titan
The edge Matinas (MTNB) has in a competitive landscape (-1.09%) 2026-05-08Real Trader Insights - Newser
What Matinas (MTNB) does that makes it resilient (Institutional Selling) 2026-05-08Social Momentum Signals - newser.com
Net current asset value per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Operating cash flow per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Matinas BioPharma Holdings, Inc. (MTNB) - Minichart
Sell Signal: Will Matinas BioPharma Holdings Inc benefit from government policy2026 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Matinas Biopharma Holdings Inc (MTNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):